<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01278992</url>
  </required_header>
  <id_info>
    <org_study_id>2006C002P</org_study_id>
    <nct_id>NCT01278992</nct_id>
  </id_info>
  <brief_title>Rhodiola Rosea for Mental and Physical Fatigue</brief_title>
  <official_title>A Randomized Trial of Rhodiola Rosea for Mental and Physical Fatigue in Nurses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Government of Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this trial is to assess whether Rhodiola rosea improves fatigue when
      compared to placebo in nurses involved in shift work.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">April 2011</completion_date>
  <primary_completion_date type="Anticipated">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue</measure>
    <time_frame>42 days</time_frame>
    <description>A vitality subscale of the generic health-related quality of life instrument, RAND-36, will be employed to assess fatigue.
A Visual Analogue Scale for Fatigue (VAS-F) will be concurrently administered to assess fatigue and compare to the RAND-36 fatigue assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>42 days</time_frame>
    <description>The health-related quality of life, RAND-36 will also assess physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social function, emotional well-being,and general health perceptions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individualized Outcomes</measure>
    <time_frame>42 days</time_frame>
    <description>Measure Yourself Medical Outcomes Profiles to measure change in items of importance to the participant, as identified by the participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adaptive Capacity</measure>
    <time_frame>42 days</time_frame>
    <description>Adaptive Capacity Index - 21 item questionnaire to measure a subject's ability to adapt to stressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event Monitoring</measure>
    <time_frame>42 days</time_frame>
    <description>number of patients with any untoward medical occurance as a measure of safety</description>
  </secondary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Fatigue</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Rhodiola rosea</intervention_name>
    <description>1 capsule = 182 mg Rhodiola rosea extract standardized to 2.8% total rosavins. Take 2 capsules at start of wakeful period each day. Participants will self-determine need for second dose, of 1 capsule, within 4 hours of the initial dose.</description>
    <other_name>University of Alberta Lot Number 120910</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fourth year nursing students enrolled in NURS 495 (Nursing Practice)

          -  Participating in permanent overnight (between 11 pm and 7 am) or rotating shift work

          -  otherwise healthy

          -  consent to participate in the study

        Exclusion Criteria:

          -  nurses aged 18 years or younger

          -  breastfeeding or pregnant women, as confirmed by a blood test

          -  female participants with child bearing potential not practicing a form of birth
             control throughout the trial

          -  presence of a primary medical condition associated with fatigue (e.g. cardiac,
             gastrointestinal, respiratory, renal, rheumatologic, or oncologic disease)

          -  presence of schizophrenia, bipolar disorder, dementia, eating disorders, insomnia or
             substance abuse

          -  presence of diabetes

          -  concurrent utilization of hypoglycaemic or agents for raising or lowering blood
             pressure

          -  known allergy or hypersensitivity to Rhodiola rosea or Sedum family extracts or pollen

          -  know allergy to microcrystalline cellulose or silicone dioxide

          -  concurrent utilization of stimulant drug such as methylphenidate (Ritalin),
             amphetamine (Dexedrine, Adderall), methamphetamine (Desoxyn) and pemoline (Cylert)

          -  concurrent utilization of other rhodiola or ginseng products (both fall in the same
             therapeutic category known as an &quot;adaptogen&quot;)

          -  any significant medical condition

          -  any neurological or mental health condition

          -  taking medication that has central nervous system effects

          -  aged 55 years or older

          -  low blood pressure or history of significant dizziness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunita Vohra, MD FRCPC MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2E1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2011</study_first_submitted>
  <study_first_submitted_qc>January 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2011</study_first_posted>
  <last_update_submitted>February 14, 2011</last_update_submitted>
  <last_update_submitted_qc>February 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Susan Lutz, Manager - Functional Foods and Natural Health Products</name_title>
    <organization>Government of Alberta</organization>
  </responsible_party>
  <keyword>fatigue</keyword>
  <keyword>adaptogen</keyword>
  <keyword>Rhodiola rosea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

